Regulatory Readiness

Some health authorities have developed specialised approval pathways and reimbursement codes for PDTx, while others place them under broad mobile health categories. Post-market oversight descriptors in the framework will assess real-world evidence expectations, safety monitoring, and feedback loops. The regulatory readiness domain of the framework assesses whether the system has clear regulatory capacity for PDTx, including classification, oversight, and software as a medical device policy.